Connect Biopharma Holdings Ltd Balance Sheet
CNTB|2 years of annual SEC 10-K data (FY2024-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$56M
FY2025
Cash
$38M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$42M
FY2025
Connect Biopharma Holdings Ltd had $56M in total assets and $42M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash & Equivalents | $38.3M | $78.2M |
| Accounts Receivable | $13.0K | $789.0K |
| Current Assets | $50.9M | $97.0M |
| PP&E (Net) | $3.8M | $4.0M |
| Total Assets | $56.1M | $101.3M |
| Current Liabilities | $13.6M | $8.5M |
| Shareholders' Equity | $42.0M | $101.5M |